SLNSilence Therapeutics plcUptrendEarnings in 9 days

TodayUptrend

Nasdaq GMBiotechnologyMarket cap $1.23BReports Nov 5, 2026

Silence Therapeutics plc

Rare disease
Sector
Healthcare
Industry
Biotechnology
Market cap
$1.23B
Employees
88
Exchange
Nasdaq GM
Country
United Kingdom
19.78+0.56% todayClose of Oct 26, 2026 · end-of-day snapshot

Not sure what's inside? Read a full TSLA analysis, currently free

Figures as of Oct 26, 2026Unlock all 8$9.90one-time

Technical readingsFree

Trend state Uptrend, stage 2 of 4, no damage flags raised (as of Oct 26, 2026)

Automated read

Price is trading above its key moving averages, but momentum readings are in extended territory: the mid-term picture reads as a stretched uptrend. RSI is currently 80.

Readings, end-of-day Oct 26, 2026
RSI (14)Overbought zone79.57, flagged reading
MACD / signalAbove signal line1.83 / 0.54, favorable reading
SMA 50Price above12.88, favorable reading
SMA 200Price above8.71, favorable reading
EMA 20Price above13.97, favorable reading
ADX (14)Trending45.85
Show all 12 readings
+DI / −DI+DI leading57.76 / 13.24, favorable reading
ATR (14)6.3% of price — elevated daily swings1.25, flagged reading
Stochastic %KOverbought zone99.82, flagged reading
Bollinger bands (20)Inside bands3.63 – 21.09
ROC (10)Positive over 10 sessions99.49, favorable reading
Trend / momentum impulseTrend and momentum disagreeMixed
Full analysis

What unlocking SLN reveals

Company & theme write-upWhat the company does, the themes it belongs to, and the tags that place it beside its peers.Generated on unlock
Signal historyEvery past volume signal measured forward from the day it fired.Generated on unlock
AI narrativeThe volume, technical and fundamental reads tied into one plain-language story.Generated on unlock
Catalysts & risksScheduled events set beside the risks the narrative flags, each paired to its figure.Generated on unlock
Accumulation readVolume measured against this stock's own baseline, broken down day by day.Generated on unlock

Generated on unlock: written when SLN's analysis runs, rather than checked against its stored data now.

Every section above, argued on SLN's own numbers, on one page.

See what SLN costsNot sure what's inside? Read a full TSLA analysis, currently free

Unlock the full SLN analysis

AI narrative, signals and history, social sentiment and the full fundamentals, refreshed each market day for 30 days.

  • Unlocked in about 60 seconds
  • No account needed
  • Secure checkout via Stripe

Covering a bigger list? Get 15 for $49.00: one-time, 30 days for the whole pack, swaps included.

Free weekly sample report

Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.

Need the raw data?Get SLN + ~23,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset
Earnings

When does Silence Therapeutics plc report earnings?

Silence Therapeutics plc (SLN) is scheduled to report earnings on Nov 5, 2026.

The date is confirmed rather than estimated, though companies do occasionally reschedule.

Data as of Oct 27, 2026

See who else reports soon
Data dictionary
$9.90one-time Unlock SLN